麻豆区

Dr. Rana Khan

On Nov. 14, 2019, Dr. Rana Khan, director of the MS in Biotechnology Management and Entrepreneurship at the , hosted 鈥淲orking in Biotech: The Exciting and Challenging Parts,鈥� a forum brought to New York City by Academia to Industry (A2I), which is part of , an Israel-based nonprofit organization that harnesses the power of senior Israeli scientists living abroad. According to its website, the mission of A2I is 鈥渂uilding a global life-science industry network to expand the opportunities for Israeli scientists around the world to form connections and collaborations among themselves [and] enable talented Israeli scientists to augment their extensive research expertise with the skill set required to successfully advance the life science industry worldwide and in Israel.鈥� This event, the first of its kind held by A2I, drew more than 35 attendees who came to learn about how to establish and manage a biotech startup, including Israeli academic scientists, members of ScienceAbroad and biotech executives and entrepreneurs of related industries, both Israeli and friends of Israel. The roster of panelists included:

• Dr. Boris Shor: founder and CEO of Manhattan BioSolutions and founder of BioIDEA
• Dr. Sarah Bettigole: co-founder and director of biology for Quentis Therapeutics
• Golan Vaknin: founder and executive director of ESEV
• Dr. Dan Zekzer: principal & co-founder of Match DIscovery

鈥淭he goal of the A2I forum is to create an environment for communication between academic scientists and biotech professionals,鈥� said Dr. Khan. 鈥淲e鈥檙e glad to be part of a collaboration between Israeli biotech companies in Israel and United States as well as with all the incubators and accelerators operating globally to support A2I.鈥�

Attendees at the A2I forum get down to serious networking about biotech and entrepreneurship